{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T07:04:41Z","timestamp":1771657481462,"version":"3.50.1"},"reference-count":45,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CHR"],"published-print":{"date-parts":[[2021,5,6]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>The clinical spectrum of SARS-CoV-2 infection may vary from simple\ncolds to a severe acute respiratory syndrome, metabolic acidosis, septic shock, and multiple organ\nfailure. Current evidence indicates that the risk of severe illness increases with age, in the male sex,\nand with certain chronic medical problems. Many people living with HIV have other conditions\nthat increase their risk.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Case presentation:<\/jats:title>\n<jats:p>In the first 3 months of the pandemic, four patients with HIV were hospitalized\nin our clinic because of COVID-19. The disease severity was mild in two patients with normal\nCD4+ T count. However, one patient with a low CD4+T count died and the other developed retinal\ndetachment one month after discharge. The deceased patient had a malignancy.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>In this study, the effect of the immunological status of the patients on the course of\nCOVID-19 and the developing vascular complications was evaluated in 4 patients with HIV.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1570162x18666201201093540","type":"journal-article","created":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T04:07:31Z","timestamp":1606882051000},"page":"286-291","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Course of COVID-19 in Four Patients with HIV During the Pandemic"],"prefix":"10.2174","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9536-6560","authenticated-orcid":true,"given":"Melda","family":"Turken","sequence":"first","affiliation":[{"name":"University of Health Sciences, Izmir Tepecik Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Yenisehir, Konak, Izmir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hividar","family":"Altan","sequence":"additional","affiliation":[{"name":"University of Health Sciences, Izmir Tepecik Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Yenisehir, Konak, Izmir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9076-428X","authenticated-orcid":true,"given":"Sabri","family":"Atalay","sequence":"additional","affiliation":[{"name":"University of Health Sciences, Izmir Tepecik Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Yenisehir, Konak, Izmir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4228-1213","authenticated-orcid":true,"given":"Sukran","family":"Kose","sequence":"additional","affiliation":[{"name":"University of Health Sciences, Izmir Tepecik Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Yenisehir, Konak, Izmir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1056\/NEJMp2000929","volume":"382","author":"Munster V.J.","year":"2020","unstructured":"Munster V.J.; Koopmans M.; van Doremalen N.; van Riel D.; de Wit E.; A Novel Coronavirus Emerging in China - Key Questions for Impact Assessment. N Engl J Med 2020,382(8),692-694","journal-title":"N Engl J Med"},{"key":"ref=2","unstructured":"WHO announces COVID-19 outbreak a pandemic World Health Organization2020\n                     ext-link-type=\"uri\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.euro.who.int\/en\/health-topics\/health-emergencies\/coronavirus-covid-19\/news\/news\/2020\/3\/who-announces-covid-19-outbreak-a-pandemic\">http:\/\/www.euro.who.int\/en\/health-topics\/health-emergencies\/coronavirus-covid-19\/news\/news\/2020\/3\/who-announces-covid-19-outbreak-a-pandemic"},{"key":"ref=3","unstructured":"Guidelines of COVID-19 General information, epidemiology and diagnosis TR2020\n                     https:\/\/covid19.saglik.gov.tr\/Eklenti\/38597\/0\/covid-19rehberigenelbilgilerepidemiyolojivetanipdf.pdf","journal-title":"General information, epidemiology and diagnosis"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"Huang C.","year":"2020","unstructured":"Huang C.; Wang Y.; Li X.; Ren L.; Zhao J.; Hu Y.; Zhang L.; Fan G.; Xu J.; Gu X.; Cheng Z.; Yu T.; Xia J.; Wei Y.; Wu W.; Xie X.; Yin W.; Li H.; Liu M.; Xiao Y.; Gao H.; Guo L.; Xie J.; Wang G.; Jiang R.; Gao Z.; Jin Q.; Wang J.; Cao B.; Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020,395(10223),497-506","journal-title":"Lancet"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"Wang D.","year":"2020","unstructured":"Wang D.; Hu B.; Hu C.; Zhu F.; Liu X.; Zhang J.; Wang B.; Xiang H.; Cheng Z.; Xiong Y.; Zhao Y.; Li Y.; Wang X.; Peng Z.; Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020,323(11),1061-1069","journal-title":"JAMA"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"Chen N.","year":"2020","unstructured":"Chen N.; Zhou M.; Dong X.; Qu J.; Gong F.; Han Y.; Qiu Y.; Wang J.; Liu Y.; Wei Y.; Xia J.; Yu T.; Zhang X.; Zhang L.; Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020,395(10223),507-513","journal-title":"Lancet"},{"key":"ref=7","year":"2020","unstructured":"EACS \u00a0 BHIVA Statement on risk of COVID-19 for people living with HIV (PLWH) COVID-19"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","volume":"382","author":"Cao B.","year":"2020","unstructured":"Cao B.; Wang Y.; Wen D.; Liu W.; Wang J.; Fan G.; Ruan L.; Song B.; Cai Y.; Wei M.; Li X.; Xia J.; Chen N.; Xiang J.; Yu T.; Bai T.; Xie X.; Zhang L.; Li C.; Yuan Y.; Chen H.; Li H.; Huang H.; Tu S.; Gong F.; Liu Y.; Wei Y.; Dong C.; Zhou F.; Gu X.; Xu J.; Liu Z.; Zhang Y.; Li H.; Shang L.; Wang K.; Li K.; Zhou X.; Dong X.; Qu Z.; Lu S.; Hu X.; Ruan S.; Luo S.; Wu J.; Peng L.; Cheng F.; Pan L.; Zou J.; Jia C.; Wang J.; Liu X.; Wang S.; Wu X.; Ge Q.; He J.; Zhan H.; Qiu F.; Guo L.; Huang C.; Jaki T.; Hayden F.G.; Horby P.W.; Zhang D.; Wang C.; A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med 2020,382(19),1787-1799","journal-title":"N Engl J Med"},{"key":"ref=9","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104786","volume":"178","author":"Choy K.T.","year":"2020","unstructured":"Choy K.T.; Wong A.Y.; Kaewpreedee P.; Sia S.F.; Chen D.; Hui K.P.Y.; Chu D.K.W.; Chan M.C.W.; Cheung P.P.; Huang X.; Peiris M.; Yen H.L.; Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro. Antiviral Res 1047862020,178","journal-title":"Antiviral Res"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.apsb.2020.02.008","volume":"10","author":"Wu C.","year":"2020","unstructured":"Wu C.; Liu Y.; Yang Y.; Zhang P.; Zhong W.; Wang Y.; Wang Q.; Xu Y.; Li M.; Li X.; Zheng M.; Chen L.; Li H.; Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm Sin B 2020,10(5),766-788","journal-title":"Acta Pharm Sin B"},{"key":"ref=11","author":"Chien M.","unstructured":"Chien M.; Anderson T.K.; Jockusch S.; Tao C.; Kumar S.; Li X.; Nucleotide Analogues as Inhibitors of SARS-CoV-2 2020\n                     ext-link-type=\"uri\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.biorxiv.org\/content\/10.1101\/2020.03.18.997585v1\">www.biorxiv.org\/content\/10.1101\/2020.03.18.997585v1"},{"key":"ref=12","unstructured":"Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) Healthcare Personnel (EPICOS)","journal-title":"Healthcare Personnel (EPICOS)"},{"key":"ref=13","author":"Guo W.","year":"2020","unstructured":"Guo W.; Ming F.; Dong Y.; Zhang Q.; Zhang X.; Mo P.; Feng Y.; Liang K.; A Survey for COVID-19 among HIV\/AIDS Patients in Two Districts of Wuhan, China Preprint research paper, Lancet 2020","journal-title":"Preprint research paper, Lancet"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"e314","DOI":"10.1016\/S2352-3018(20)30111-9","volume":"7","author":"Blanco J.L.","year":"2020","unstructured":"Blanco J.L.; Ambrosioni J.; Garcia F.; Mart\u00ednez E.; Soriano A.; Mallolas J.; Miro J.M.; COVID-19 in patients with HIV: clinical case series. Lancet HIV COVID-19 in HIV Investigators2020,7(5),e314-e316","journal-title":"Lancet HIV"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s15010-020-01438-z","volume":"48","author":"H\u00e4rter G.","year":"2020","unstructured":"H\u00e4rter G.; Spinner C.D.; Roider J.; Bickel M.; Krznaric I.; Grunwald S.; Schabaz F.; Gillor D.; Postel N.; Mueller M.C.; M\u00fcller M.; R\u00f6mer K.; Schewe K.; Hoffmann C.; COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients. Infection 2020,48(5),681-686","journal-title":"Infection"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1172\/JCI137244","volume":"130","author":"Chen G.","year":"2020","unstructured":"Chen G.; Wu D.; Guo W.; Cao Y.; Huang D.; Wang H.; Wang T.; Zhang X.; Chen H.; Yu H.; Zhang X.; Zhang M.; Wu S.; Song J.; Chen T.; Han M.; Li S.; Luo X.; Zhao J.; Ning Q.; Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest 2020,130(5),2620-2629","journal-title":"J Clin Invest"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/cid\/ciaa248","volume":"71","author":"Qin C.","year":"2020","unstructured":"Qin C.; Zhou L.; Hu Z.; Zhang S.; Yang S.; Tao Y.; Xie C.; Ma K.; Shang K.; Wang W.; Tian D.S.; Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis 2020,71(15),762-768","journal-title":"Clin Infect Dis"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ijid.2004.07.014","volume":"9","author":"He Z.","year":"2005","unstructured":"He Z.; Zhao C.; Dong Q.; Zhuang H.; Song S.; Peng G.; Dwyer D.E.; Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets. Int J Infect Dis 2005,9(6),323-330","journal-title":"Int J Infect Dis"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.1038\/s41467-020-17240-2","volume":"11","author":"Song J.W.","year":"2020","unstructured":"Song J.W.; Zhang C.; Fan X.; Meng F.P.; Xu Z.; Xia P.; Cao W.J.; Yang T.; Dai X.P.; Wang S.Y.; Xu R.N.; Jiang T.J.; Li W.G.; Zhang D.W.; Zhao P.; Shi M.; Agrati C.; Ippolito G.; Maeurer M.; Zumla A.; Wang F.S.; Zhang J.Y.; Immunological and inflammatory profiles in mild and severe cases of COVID-19. Nat Commun 2020,11(1),3410","journal-title":"Nat Commun"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1093\/infdis\/jiaa150","volume":"221","author":"Wang F.","year":"2020","unstructured":"Wang F.; Nie J.; Wang H.; Zhao Q.; Xiong Y.; Deng L.; Song S.; Ma Z.; Mo P.; Zhang Y.; Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia. J Infect Dis 2020,221(11),1762-1769","journal-title":"J Infect Dis"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","volume":"11","author":"Diao B.","year":"2020","unstructured":"Diao B.; Wang C.; Tan Y.; Chen X.; Liu Y.; Ning L.; Chen L.; Li M.; Liu Y.; Wang G.; Yuan Z.; Feng Z.; Zhang Y.; Wu Y.; Chen Y.; Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19). Front Immunol 2020,11,827","journal-title":"Front Immunol"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/infdis\/jiaa380","volume":"223","author":"Ho H.","year":"2020","unstructured":"Ho H.; Peluso M.J.; Margus C.; Lopes J.P.M.; He C.; Gaisa M.M.; Clinical Outcomes and Immunologic Characteristics of Coronavirus Disease 2019 in People With HumanImmunodeficiency Virus. J Infect Dis brief report 2020,223(3),403-8","journal-title":"J Infect Dis brief report"},{"key":"ref=23","unstructured":"Ministry of Health, Turkey Guidelines of COVID-19. Adult Patient Treatment 2020\n                     https:\/\/covid19.saglik.gov.tr\/Eklenti\/38355\/0\/covid-19rehberieriskinhastatedavisipdf.pdf"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3906\/sag-2004-145","volume":"50","author":"\u015eim\u015fek Yavuz S.","year":"2020","unstructured":"\u015eim\u015fek Yavuz S.; \u00dcnal S.; Antiviral treatment of COVID-19. Turk J Med Sci 2020,50(SI-1),611-619","journal-title":"Turk J Med Sci"},{"key":"ref=25","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1009","author":"Mitj\u00e0 O.","year":"2020","unstructured":"Mitj\u00e0 O.; Corbacho-Monn\u00e9 M.; Ubals M.; Tebe C.; Pe\u00f1afiel J.; Tobias A.; Ballana E.; Alemany A.; Riera-Mart\u00ed N.; P\u00e9rez C.A.; Su\u00f1er C.; Laporte P.; Admella P.; Mitj\u00e0 J.; Clua M.; Bertran L.; Sarquella M.; Gavil\u00e1n S.; Ara J.; Argimon J.M.; Casabona J.; Cuatrecasas G.; Ca\u00f1adas P.; Elizalde-Torrent A.; Fabregat R.; Farr\u00e9 M.; Forcada A.; Flores-Mateo G.; Muntada E.; Nadal N.; Narejos S.; Gil-Ortega A.N.; Prat N.; Puig J.; Qui\u00f1ones C.; Reyes-Ure\u00f1a J.; Ram\u00edrez-Viaplana F.; Ruiz L.; Riveira-Mu\u00f1oz E.; Sierra A.; Velasco C.; Vivanco-Hidalgo R.M.; Sent\u00eds A.; G-Beiras C.; Clotet B.; Vall-Mayans M.; Hydroxychloroquine for early treatment of adults with mild Covid-19: a randomized- controlled trial. Clin Infect Dis BCN PEP-CoV-2 RESEARCH GROUP [Online ahead of print]2020","journal-title":"Clin Infect Dis"},{"key":"ref=26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2019014","author":"Cavalcanti A.B.","year":"2020","unstructured":"Cavalcanti A.B.; Zampieri F.G.; Rosa R.G.; Azevedo L.C.P.; Veiga V.C.; Avezum A.; Hydroxychloroquine with or without azithromycin in mild-to-moderate Covid-19. N Eng J Med  [Online ahead of print]2020","journal-title":"N Eng J Med"},{"key":"ref=27","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.19.20136093","author":"Chen L.","year":"2020","unstructured":"Chen L.; Zhang Z.Y.; Fu J.G.; Feng Z.P.; Zhang S.Z.; Han Q.Y.; Efficacy and safety of chloroquine or hydroxychloroquine in moderate type of COVID-19: a prospective openlabel randomized controlled study.   medRxiv 2020","journal-title":"medRxiv"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ijid.2020.06.099","volume":"97","author":"Arshad S.","year":"2020","unstructured":"Arshad S.; Kilgore P.; Chaudhry Z.S.; Jacobsen G.; Wang D.D.; Huitsing K.; Brar I.; Alangaden G.J.; Ramesh M.S.; McKinnon J.E.; O\u2019Neill W.; Zervos M.; Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19. Int J Infect Dis Henry Ford COVID-19 Task Force2020,97,396-403","journal-title":"Int J Infect Dis"},{"key":"ref=29","doi-asserted-by":"publisher","DOI":"10.1101\/2020.09.16.20194571","author":"Axfors C.","year":"2020","unstructured":"Axfors C.; Schmitt A.M.; Janiaud P.; van 't Hooft J.; Abd-Elsalam S.; Abdo E.F.; Mortality outcomes with hydroxychloroquine and chloroquine 2 in COVID-19: an international collaborative meta-analysis of randomized trials. medRxiv 2020","journal-title":"medRxiv"},{"key":"ref=30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.106144","volume":"56","author":"Catteau L.","year":"2020","unstructured":"Catteau L.; Dauby N.; Montourcy M.; Bottieau E.; Hautekiet J.; Goetghebeur E.; van Ierssel S.; Duysburgh E.; Van Oyen H.; Wyndham-Thomas C.; Van Beckhoven D.; Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a nationwide observational study of 8075 participants. Int J Antimicrob Agents Belgian Collaborative Group on COVID-19 Hospital Surveillance 106144.2020,56(4)","journal-title":"Int J Antimicrob Agents"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"30335","DOI":"10.1016\/j.ejim.2020.08.019","volume":"S0953-6205","year":"2020","unstructured":"Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study. Eur J Intern Med COVID-19 RISK and Treatments (CORIST) Collaboration2020,S0953-6205(20),30335-6","journal-title":"Eur J Intern Med"},{"key":"ref=32","first-page":"215","volume":"49","author":"Chen J.","year":"2020","unstructured":"Chen J.; Liu D.; Liu L.; Liu P.; Xu Q.; Xia L.; A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease-19 (COVID-19). Zhejiang Da Xue Xue Bao Yi Xue Ban 2020,49(2),215-219","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"ref=33","doi-asserted-by":"publisher","DOI":"10.1101\/2020.07.15.20151852v1","author":"Horby P.W.","year":"2020","unstructured":"Horby P.W.; Mafham M.; Linsell L.; Bell J.L.; Staplin N.; Emberson J.R.; Effect of hydroxychloroquine in hospitalized patients with COVID-19: preliminary results from a multi-centre, randomized, controlled trial.   medRxiv RECOVERY Collaborative Group2020","journal-title":"medRxiv"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/jmcb\/mjaa014","volume":"12","author":"Huang M.","year":"2020","unstructured":"Huang M.; Tang T.; Pang P.; Li M.; Ma R.; Lu J.; Shu J.; You Y.; Chen B.; Liang J.; Hong Z.; Chen H.; Kong L.; Qin D.; Pei D.; Xia J.; Jiang S.; Shan H.; Treating COVID-19 with Chloroquine. J Mol Cell Biol 2020,12(4),322-325","journal-title":"J Mol Cell Biol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"623","DOI":"10.7326\/M20-4207","volume":"173","author":"Skipper C.P.","year":"2020","unstructured":"Skipper C.P.; Pastick K.A.; Engen N.W.; Bangdiwala A.S.; Abassi M.; Lofgren S.M.; Williams D.A.; Okafor E.C.; Pullen M.F.; Nicol M.R.; Nascene A.A.; Hullsiek K.H.; Cheng M.P.; Luke D.; Lother S.A.; MacKenzie L.J.; Drobot G.; Kelly L.E.; Schwartz I.S.; Zarychanski R.; McDonald E.G.; Lee T.C.; Rajasingham R.; Boulware D.R.; Hydroxychloroquine in nonhospitalized adults with early COVID-19: a randomized trial. Ann Intern Med 2020,173(8),623-631","journal-title":"Ann Intern Med"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"m1849","DOI":"10.1136\/bmj.m1849","volume":"369","author":"Tang W.","year":"2020","unstructured":"Tang W.; Cao Z.; Han M.; Wang Z.; Chen J.; Sun W.; Wu Y.; Xiao W.; Liu S.; Chen E.; Chen W.; Wang X.; Yang J.; Lin J.; Zhao Q.; Yan Y.; Xie Z.; Li D.; Yang Y.; Liu L.; Qu J.; Ning G.; Shi G.; Xie Q.; Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial. BMJ 2020,369,m1849","journal-title":"BMJ"},{"key":"ref=37","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.17.20037432.","author":"Chen C.","year":"2020","unstructured":"Chen C.; Zang Y.; Huang J.; Yin P.; Cheng Z.; Wu J.; Favipiravir versus arbidol for COVID-19: a randomized clinical trial medRxiv 2020","journal-title":"medRxiv"},{"key":"ref=38","unstructured":"Glenmark announces top-line results from phase 3 clinical trial of favipiravir in patients with mild to moderate COVID-19 Glenmark Pharmaceuticals Ltd2020\n                     https:\/\/www.glenmarkpharma.com\/sites\/default\/files\/Glenmark-Announces-Top-LineResults-From-Phase-3%20-Clinical.pdf"},{"key":"ref=39","year":"2020","unstructured":"Preliminary Report of the Favipiravir Observational Study in Japan Favipiravir Observational Study Group2020","journal-title":"Preliminary Report of the Favipiravir Observational Study in Japan"},{"key":"ref=40","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1176","author":"Ivashchenko A.A.","year":"2020","unstructured":"Ivashchenko A.A.; Dmitriev K.A.; Vostokova N.V.; Azarova V.N.; Blinow A.A.; Egorova A.N.; Gordeev I.G.; Ilin A.P.; Karapetian R.N.; Kravchenko D.V.; Lomakin N.V.; Merkulova E.A.; Papazova N.A.; Pavlikova E.P.; Savchuk N.P.; Simakina E.N.; Sitdekov T.A.; Smolyarchuk E.A.; Tikhomolova E.G.; Yakubova E.V.; Ivachtchenko A.V.; AVIFAVIR for treatment of patients with moderate COVID-19: interim results of a phase II\/III multicenter randomized clinical trial. Clin Infect Dis  [Online ahead of print].2020","journal-title":"Clin Infect Dis"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.antiviral.2015.08.015","volume":"123","author":"Madelain V.","year":"2015","unstructured":"Madelain V.; Oestereich L.; Graw F.; Nguyen T.H.T.; de Lamballerie X.; Mentr\u00e9 F.; G\u00fcnther S.; Guedj J.; Ebola virus dynamics in mice treated with favipiravir. Antiviral Res 2015,123,70-77","journal-title":"Antiviral Res"},{"key":"ref=42","first-page":"322","volume":"7","author":"Geam\u0103nu Panc\u0103 A.","year":"2014","unstructured":"Geam\u0103nu Panc\u0103 A.; Popa-Cherecheanu A.; Marinescu B.; Geam\u0103nu C.D.; Voinea L.M.; Retinal toxicity associated with chronic exposure to hydroxychloroquine and its ocular screening. Review. J Med Life 2014,7(3),322-326","journal-title":"J Med Life"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/S0140-6736(20)31014-X","volume":"395","author":"Marinho P.M.","year":"2020","unstructured":"Marinho P.M.; Marcos A.A.A.; Romano A.C.; Nascimento H.; Belfort R.; Retinal findings in patients with COVID-19. Lancet 2020,395(10237),1610","journal-title":"Lancet"},{"key":"ref=44","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmni.2020.100669","volume":"35","author":"Sharifi-Razavi A.","year":"2020","unstructured":"Sharifi-Razavi A.; Karimi N.; Rouhani N.; COVID-19 and intracerebral haemorrhage: causative or coincidental? New Microbes New Infect 2020,35","journal-title":"New Microbes New Infect"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1515\/cclm-2020-0502","volume":"58","author":"Harenberg J.","year":"2020","unstructured":"Harenberg J.; Favaloro E.; COVID-19: progression of disease and intravascular coagulation - present status and future perspectives. Clin Chem Lab Med 2020,58(7),1029-1036","journal-title":"Clin Chem Lab Med"}],"container-title":["Current HIV Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/188537","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/188537\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/188537","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T23:44:25Z","timestamp":1634341465000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/188537\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,6]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570162x18666201201093540","relation":{},"ISSN":["1570-162X"],"issn-type":[{"value":"1570-162X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-06-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-01","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}